A Prospective, Double Blinded, Randomized, Comparative Study to Evaluate the Efficacy of Investigational Drug M. Libido, in Enhancing Testosterone Level and Improving Sperm Profile in Male Volunteers. - Male Libido

Aurea Biolabs Pvt Ltd0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Male subjects of age range between 21-55 years olds
•2.Healthy heterosexual males interested in increasing libido
•3.Committed sexual relationship for at least 6 months
•4.Sexually active for the last 6 months
•5.Stable, sexual relationship for the duration of the study
•6.Total testosterone levels within the healthy reference range (Endocrine Society) at screening (264 - 916 ng/dL) â?? could target men at lower end of the healthy testosterone range (low normal).

•Allergy or intolerance to study ingredients
•Any physical unavailability to sexual partner during duration of study
•Any physical disability that limits sexual function
•Treatment or therapy for sexual disorder during the last 6 months
•Prescribed medication for anticoagulation therapy.
•Diagnosed with any medical disorders or diseases such as severe renal/hepatic insufficiency, psychiatric disorders, prostatic cancer or benign hypertrophy, acute genitourinary disorder or any other conditions that identify the subject as unhealthy for the study or interfere with any study parameters.
•Diagnosed with hypertension and receiving medications for hypertension

发起方

Aurea Biolabs Pvt Ltd